Boston
Oct 1, 2026
Arkeabio Raises $7M From Breakthrough Energy Ventures
Boston-based ArkeaBio, a global agricultural bioscience company developing a vaccine to reduce methane emissions from cattle, raised $7M Series A+ from Breakthrough Energy Ventures.
TradedVC
Traded Media
Traded Editorial
1 min read
ArkeaBio raises $7M in a series a+ from Breakthrough Energy Ventures.
Boston-based ArkeaBio a global agricultural bioscience company developing a vaccine to reduce methane emissions from cattle. CEO Arkea Bio Frank leads the company.
| Company | ArkeaBio |
|---|---|
| HQ | Boston |
| Round | Series A+ |
| Amount | $7M |
| Lead investor | Breakthrough Energy Ventures |
| Founders | Arkea Bio Frank (CEO), Names Frank Wooten (CEO) |
| Sector | agricultural bioscience |
| Source | Finsmes |
Published: Oct 1, 2026Last updated: October 1, 2026